pharmaoffer.com

What It Is

Pharmaoffer is an API supplier and CDMO/CRO/CMO sourcing platform for the global pharmaceutical supply chain. It brings together APIs, small molecules, biologics, peptides, oligonucleotides, intermediates, fine chemicals, as well as outsourced formulation services such as oral solids, sterile injectables, ophthalmics, nasal products, and inhalation products in a single directory, helping buyers search, compare, and contact pre-qualified suppliers.

Core Features and Workflow

The platform is built around “search and compare — contact or purchase — sourcing support — close the deal.” Users can filter CDMOs or suppliers by manufacturing region, production scale, GMP/FDA/EMA qualifications, and other criteria. They can also send open RFQs, with the platform helping clarify requirements, match suppliers, and drive comparable quotations. The site also mentions in-platform chat, direct supplier contact, small-batch API online purchasing, audit report requests, and Sourcing Intelligence based on pricing, transaction volume, and trade activity. For overseas companies entering the Chinese market, it also provides an entry point for cDMF registration consulting, covering compliance services related to NMPA, CDE, and DMF dossier preparation.

Pricing and Business Model

Public information shows that buyers can “Get started – free,” and that “Suppliers cover our fees, so buyers pay nothing,” suggesting that buyer acquisition and RFQ workflows are largely free for purchasers. The site also shows a “From €249” pricing note for market intelligence-related services, but does not specify the exact plans, billing cycle, data coverage, or supplier-side fees. Companies should therefore consult Pharmaoffer directly before purchasing or committing to a sourcing workflow.

Pros and Cons

The main strengths are its strong vertical focus, coverage of APIs and multiple drug development/manufacturing outsourcing scenarios, filtering criteria that align well with real-world pharmaceutical procurement, and free buyer access plus platform-assisted communication, which can reduce early-stage sourcing costs. The drawbacks are that it provides relatively limited information from an enterprise software perspective, with no clear disclosure of third-party system integrations, team permissions, APIs, data security certifications, or service SLAs. Final quality audits, contract negotiations, and supplier risk management still need to be handled by the buyer.

Who It’s For and Access from China

It is suitable for pharmaceutical procurement teams, supplier management teams, R&D-focused Biotech companies, distributors, and project teams looking for CDMO/CMO partners. The site does not specify access conditions from China, nor does it disclose payment methods. For China-based procurement, users may also compare alternatives such as 药智网, 摩贝, CPhI Online, and Pharmacompass.